Content about Pharmacology

October 1, 2012

How do patients want to get their prescription medicines and the advice that comes with them? In person, face to face, with their pharmacist.

How do patients want to get their prescription medicines and the advice that comes with them? In person, face to face, with their pharmacist.

October 1, 2012

More than 20,000 RxAlly member pharmacies — including independent pharmacies, regional chains and Walgreens — will begin accepting a new federally qualified Medicare Prescription Drug Plan, SmartD Rx, beginning Jan. 1, 2013.

CLEVELAND — More than 20,000 RxAlly member pharmacies — including independent pharmacies, regional chains and Walgreens — will begin accepting a new federally qualified Medicare Prescription Drug Plan, SmartD Rx, beginning Jan. 1, 2013. Developed by Smart Insurance Company with the input of pharmacists, SmartD Rx will be offered to beneficiaries for the first time this fall during Medicare’s open enrollment period. 

September 28, 2012

Supermarket chain Bi-Lo is adding the generic form of a blood-thinning drug to its generic-discount program.

JACKSONVILLE, Fla. — Supermarket chain Bi-Lo is adding the generic form of a blood-thinning drug to its generic-discount program.

The company announced Friday that patients could buy generic clopidogrel for $4 for a 30-day supply and $10 for a 90-day supply with the chain's Pharmacy Discount Card. The branded version of the drug, which recently became available as a generic, is marketed by Sanofi and Bristol-Myers Squibb.

September 28, 2012

Generic drug maker Mylan has received regulatory approval for a drug used to treat high blood pressure, also known as hypertension, the company said Friday.

PITTSBURGH — Generic drug maker Mylan has received regulatory approval for a drug used to treat high blood pressure, also known as hypertension, the company said Friday, saying that it would launch both drugs immediately.

Mylan said the Food and Drug Administration approved its irbesartan tablets in the 75 mg, 150 mg and 300 mg strengths and irbesartan and hydrochlorothiazide tablets in the 150 mg/12.5 mg and 300 mg/12.5 mg strengths. The drugs are respectively generic versions of Sanofi's Avapro and Avalide.

September 28, 2012

The Food and Drug Administration has launched a campaign designed to educate consumers about online rogue pharmacies, the agency said Friday.

SILVER SPRING, Md. — The Food and Drug Administration has launched a campaign designed to educate consumers about online rogue pharmacies, the agency said Friday.

The FDA announced the launch of BeSafeRx, which includes resources for patients and caregivers who might purchase medications online.

September 28, 2012

Keynote speeches by pharmaceutical industry and regulatory leaders got top billing as more than 140 government, healthcare industry, law enforcement and patient advocacy officials gathered to find ways to combat the spread of counterfeit medicines.

WASHINGTON — Keynote speeches by pharmaceutical industry and regulatory leaders got top billing as more than 140 government, healthcare industry, law enforcement and patient advocacy officials gathered to find ways to combat the spread of counterfeit medicines.

September 28, 2012

Sticker shock is often a major factor in any person's purchasing decisions, but while deciding to put off buying a new car might not have catastrophic consequences, not filling a prescription because it costs too much can.

WHAT IT MEANS AND WHY IT'S IMPORTANT — Sticker shock is often a major factor in any person's purchasing decisions, but while deciding to put off buying a new car might not have catastrophic consequences, not filling a prescription because it costs too much can.

(THE NEWS: Pharmacists say cost is biggest barrier to Rx adherence. Click here to read the story.) 

September 28, 2012

The Food and Drug Administration has approved a treatment for psoriasis of the scalp made by a subsidiary of British drug maker GlaxoSmithKline.

 RESEARCH TRIANGLE PARK, N.C. — The Food and Drug Administration has approved a treatment for psoriasis of the scalp made by a subsidiary of British drug maker GlaxoSmithKline.

Stiefel announced Friday the approval of Sorilux (calcipotriene) foam for psoriasis of the scalp in adults. The drug was already approved for psoriasis of other parts of the body in October 2010.

September 28, 2012

Fiscal 2012 is now in Walgreens' rearview mirror as the company looks ahead toward 2013 with its foot on the accelerator

 DEERFIELD, Ill. — Fiscal 2012 now is in Walgreens' rearview mirror as the company looks ahead toward 2013 with its foot on the accelerator. A re-entry into the Express Scripts pharmacy provider network, a new loyalty card and synergies borne out of the Alliance Boots partnership will all help fuel Walgreens' health-and-wellness engine. 

Walgreens stock was up slightly within the half-hour of the call to approximately $36.70 per share. WAG had closed Thursday at $36.52 and opened Friday morning at $36.27. 

September 27, 2012

More than one-fifth of prescriptions given to children at clinics in Illinois were never filled, according to a new study.

NEW YORK — More than one-fifth of prescriptions given to children at clinics in Illinois were never filled, according to a new study.

September 27, 2012

In recognition of American Pharmacists Month in October, CVS Caremark released results from a new survey of CVS retail pharmacists, which underscored that cost remains a key barrier to medication adherence and reinforced the important role of the pharmacist in helping people take their chronic medications as directed.

WOONSOCKET, R.I. — In recognition of American Pharmacists Month in October, CVS Caremark released results from a new survey of CVS retail pharmacists, which underscored that cost remains a key barrier to medication adherence and reinforced the important role of the pharmacist in helping people take their chronic medications as directed.

September 27, 2012

The Food and Drug Administration has approved a new drug for colorectal cancer developed by Bayer HealthCare.

SAN FRANCISCO — The Food and Drug Administration has approved a new drug for colorectal cancer developed by Bayer HealthCare.

Bayer and Onyx Pharmaceuticals announced the approval of Stivarga for colorectal cancer that has spread to other parts of the body, also known as metastatic CRC, specifically for those patients who have received treatment with currently available therapies.

Bayer developed the drug and will pay royalties to Onyx on future global net sales of the drug for cancer. The two companies will promote the drug together in the United States.

September 27, 2012

Satisfaction among customers using mail-order pharmacies to fill their prescriptions continued to decline, falling significantly below customer satisfaction with brick-and-mortar pharmacies, according to the J.D. Power and Associates "2012 U.S. Pharmacy Study" released Thursday.

WESTLAKE VILLAGE, Calif. — Satisfaction among customers using mail-order pharmacies to fill their prescriptions continued to decline, falling significantly below customer satisfaction with brick-and-mortar pharmacies, according to the J.D. Power and Associates "2012 U.S. Pharmacy Study" released Thursday.

September 26, 2012

The U.S. subsidiary of Japanese drug maker Astellas is seeking approval from the Food and Drug Administration for a drug to prevent rejection of transplanted organs.

NORTHBROOK, Ill. — The U.S. subsidiary of Japanese drug maker Astellas is seeking approval from the Food and Drug Administration for a drug to prevent rejection of transplanted organs.

Astellas Pharma US said it applied with the FDA for approval of tacrolimus extended-release capsules to prevent rejection of transplanted kidneys in adults and transplanted livers in men. The drug was approved in Europe in 2007 under the name Advagraf and under the name Graceptor in Japan in 2008; the drug has been approved in 69 countries so far.

September 26, 2012

A drug maker is suing the Food and Drug Administration to force the agency to give a special designation to one of its drugs.

MENLO PARK, Calif. — A drug maker is suing the Food and Drug Administration to force the agency to give a special designation to one of its drugs.

Depomed announced that it had filed suit against the FDA in federal district court for the District of Columbia seeking an order that would require the agency to grant the drug Gralise (gabapentin) orphan drug exclusivity for the management of post-herpetic neuralgia. The disease, also known as PHN, is a condition causing prolonged pain in people who have had shingles, a complication of chickenpox.

September 26, 2012

The National Association of Chain Drug Stores Foundation has announced 15 additional academic institutions selected for the Community Pharmacy Residency Expansion Project (Community PREP).

ALEXANDRIA, Va. — The National Association of Chain Drug Stores Foundation has announced 15 additional academic institutions selected for the Community Pharmacy Residency Expansion Project (Community PREP).

The $1.5 million educational grant program, established in 2010, is designed to expand post-graduate community pharmacy residency opportunities for recent pharmacy school graduates. 

The following academic institutions will receive a $50,000 educational grant:

September 25, 2012

Patients diagnosed with serious disease have enough on their minds. So Walgreens is doing all it can to make it easier for them to obtain, administer and pay for their specialty and infused medicines, said Mike Ellis, VP specialty pharmacy and infusion.


Patients diagnosed with serious disease have enough on their minds. So Walgreens is doing all it can to make it easier for them to obtain, administer and pay for their specialty and infused medicines, said Mike Ellis, VP specialty pharmacy and infusion.


“The concept is to go where patients are diagnosed and where they reside. We have a large sales force who call on physicians who prescribe these types of medications. But like everything else at Walgreens, it starts with the patient.”


September 25, 2012

A vast army of some 70,000 Walgreens pharmacists, technicians, nurses and nurse practitioners, and other clinicians is poised to plug some of the gaps in the nation’s overstretched healthcare system with expanded services, greater access for patients and new solutions for providers and payers in desperate need of quality, cost-effective solutions.


A vast army of some 70,000 Walgreens pharmacists, technicians, nurses and nurse practitioners, and other clinicians is poised to plug some of the gaps in the nation’s overstretched healthcare system with expanded services, greater access for patients and new solutions for providers and payers in desperate need of quality, cost-effective solutions.


September 25, 2012

The generic drug user fee program may have hit a speed bump due to budget problems in Congress, according to published reports.

NEW YORK — The generic drug user fee program may have hit a speed bump due to budget problems in Congress, according to published reports.

Bloomberg reported that implementation of the law may be delayed because Congress must first pass legislation authorizing the Food and Drug Administration to collect money from generic drug companies, but the problem is that members of Congress will leave Washington this week, not to return until after the Nov. 6 elections.

September 25, 2012

Valeant Pharmaceuticals International has acquired rights to a drug used to treat a symptom of age-related macular degeneration, the drug maker said.

MONTREAL — Valeant Pharmaceuticals International has acquired rights to a drug used to treat a symptom of age-related macular degeneration, the drug maker said.

Valeant announced that it acquired the injected drug Visudyne (verteporfin) from QLT, a company based in Vancouver, Canada.

Valeant said it paid $62.5 million upfront for all U.S. rights and available inventories for the drug, which had U.S. sales of about $21 million in 2011, and another $50 million upfront for rights to non-U.S. sales, which were about $14 million.

September 25, 2012

Generic drug maker Watson Labs recalled two lots of a prescription painkiller due to the potential for oversized and overly potent tablets, the company said.

PARSIPPANY, N.J. — Generic drug maker Watson Labs recalled two lots of a prescription painkiller due to the potential for oversized and overly potent tablets, the company said.

The drug maker announced the recall of hydrocodone bitartrate and acetaminophen tablets in the 10 mg/500 mg strengths based on a customer complaint of tablets that were thicker and darker-colored than the others.

September 25, 2012

For the more than 100 years that Walgreens has been in operation, the company has been focused on helping its customers, communities and patients feel well. And now, it is poised to transform the traditional drug store into a health and daily living destination. 


For the more than 100 years that Walgreens has been in operation, the company has been focused on helping its customers, communities and patients feel well. And now, it is poised to transform the traditional drug store into a health and daily living destination. 


September 25, 2012

There is no doubt about it. Pharmacy audits can be time consuming and laborious for all parties involved. And as both government and commercial money gets tighter and tighter, all of health care is searching for the most effective means to manage the financial challenges associated with doing business. In addition to the clinical aspects, audits are used to identify genuinely fraudulent or erroneously paid healthcare claims. Nevertheless, a survey released in September 2012 by the National Community Pharmacists Association found that nearly 87% of those surveyed stated that reimbursement and auditing practices are “significantly” or “very significantly” affecting their ability to provide patient care and remain in business.

There is no doubt about it. Pharmacy audits can be time consuming and laborious for all parties involved. And as both government and commercial money gets tighter and tighter, all of health care is searching for the most effective means to manage the financial challenges associated with doing business. In addition to the clinical aspects, audits are used to identify genuinely fraudulent or erroneously paid healthcare claims.

September 24, 2012

It wasn’t that long ago that the branded drug industry was seen as an unstoppable titan of American industry, churning out a steady stream of breakthrough therapies and blockbuster products. But a tsunami of expiring patents on such top selling drugs as Lipitor, Plavix and Seroquel, combined with a slowdown in research and development, flattened the growth curve in recent years and opened the door for the ascendancy of generic drugs.

It wasn’t that long ago that the branded drug industry was seen as an unstoppable titan of American industry, churning out a steady stream of breakthrough therapies and blockbuster products. But a tsunami of expiring patents on such top selling drugs as Lipitor, Plavix and Seroquel, combined with a slowdown in research and development, flattened the growth curve in recent years and opened the door for the ascendancy of generic drugs.

September 24, 2012

As part of CVS Caremark's sponsorship of The Partnership at Drugfree.org's The Medicine Abuse Project, which aims to prevent a half-million teens from abusing medicine over the next five years, the company now is asking its customers to take the project's pledge to learn about teen medicine abuse, to safeguard medicines in the home and to talk to teens about this issue, the company announced on Monday.

WOONSOCKET, R.I. — As part of CVS Caremark's sponsorship of The Partnership at Drugfree.org's The Medicine Abuse Project, which aims to prevent a half-million teens from abusing medicine over the next five years, the company now is asking its customers to take the project's pledge to learn about teen medicine abuse, to safeguard medicines in the home and to talk to teens about this issue, the company announced on Monday.

CVS Caremark will use many of its communications channels to share with customers some key facts central to the awareness campaign, such as: